Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsSUBLINGUALGeneric

ERGOSTAT

ERGOTAMINE TARTRATE

Standard Dose
2MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ERGOSTAT is listed in Drugs@FDA under application 088337 (ANDA).

Marketing status: Discontinued Active ingredient ERGOTAMINE TARTRATE Form and strength TABLET;SUBLINGUAL - 2MG Sponsor WATSON LABS INC Submission history Latest submission status date: 1991-06-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview ERGOSTAT is listed in Drugs@FDA under application 088337 (ANDA). Marketing status: Discontinued Active ingredient ERGOTAMINE TARTRATE Form and strength TABLET;SUBLINGUAL - 2MG Sponsor WATSON LABS INC Submission history Latest submission status date: 1991-06-14 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
ERGOSTAT (ERGOTAMINE TARTRATE) | Drug Monograph | MedicHelpline